All three of the medications weve discussed in this piece Invokana, Jardiance, and Farxiga are relatively newer
doi: 10.1016/j.ajpath.2012.07.015 58 VendrellJEl BekayRPeralBGarca-FuentesEMegiaAMacias-GonzalezMet al
In the subsequent years, several observational studies have yielded conflicting results.4043 Notably, most of the available information is drawn from the subgroup of exendin-4-based drugs, which differ structurally from human GLP-1
Microdosing a More Balanced Way to Feel Better Personalized, low-dose GLP-1 and GIP-based formulations designed to support energy, metabolism, and everyday performance
After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology
